NCT02212795View on ClinicalTrials.gov

Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

Zabofloxacin 183mg

Zabofloxacin 183mg single dose

DRUG

Levofloxacin 250mg

Levofloxacin 250mg single dose

DRUG

Zabofloxacin 367mg

Zabofloxacin 367mg single dose

Trial Locations (1)

561-712

Chonbuk National University Hospital, Jeonju

Sponsors
All Listed Sponsors
lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY